These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 5334796
1. The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo. Marmont AM, Damasio EE. Blood; 1967 Jan; 29(1):1-21. PubMed ID: 5334796 [No Abstract] [Full Text] [Related]
2. [Clinical experience in the treatment of malignant lymphomas with Vinca rosea alkaloids]. Prato V, Mazza U, Uslenghi E, Battistini V, Bianco G. Cancro; 1968 Jan; 21():Suppl 6:79-85. PubMed ID: 4906145 [No Abstract] [Full Text] [Related]
3. [Personal experience on the chemotherapy of leukemias and hematosarcomas]. Mathé G, Schneider M, Schwarzenberg L, Cattan A, Amiel JL, Schlumberger JR. Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537 [No Abstract] [Full Text] [Related]
4. Treatment of Hodgkin's disease and other malignant lymphomas. Aungst CW. J Surg Oncol; 1973 Jun; 5(6):575-9. PubMed ID: 4589653 [No Abstract] [Full Text] [Related]
5. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases]. Cajozzo A, Citarrella P, Carreca I, D'Eredità F. Haematologica; 1970 Jun; 55(7):465-70. PubMed ID: 4996520 [No Abstract] [Full Text] [Related]
6. [Periwinkle alkaloids. Treatment of Hodgkin's disease and leukemia]. Jacquillat C, Weil M. Sem Ther; 1964 Jun; 40(6):395-400. PubMed ID: 5233529 [No Abstract] [Full Text] [Related]
7. Drug therapy for neoplastic disease in adults. Votaw ML, Bull FE. Med Clin North Am; 1969 Nov; 53(6):1265-78. PubMed ID: 4900716 [No Abstract] [Full Text] [Related]
8. [Ambulatory endoxan therapy by high doses]. Fischer M, Martin H, Schubert JC. Dtsch Med Wochenschr; 1967 Jun 23; 92(25):1145-50. PubMed ID: 5338225 [No Abstract] [Full Text] [Related]
9. [The treatment of some infantile malignant neoplasms with Vinca rosea alkaloids]. Nigro N, Madon E. Cancro; 1968 Jun 23; 21():Suppl 6:119+. PubMed ID: 4313386 [No Abstract] [Full Text] [Related]
10. VINCRISTINE IN THE TREATMENT OF NEOPLASTIC DISEASE. WHITELAW DM, KIM HS. Can Med Assoc J; 1964 Jun 20; 90(25):1385-9. PubMed ID: 14158543 [Abstract] [Full Text] [Related]
11. Recent advances in chemotherapy of lymphoma. Lenhard RE, Owens AH. Johns Hopkins Med J; 1967 Aug 20; 121(2):136-40. PubMed ID: 5340335 [No Abstract] [Full Text] [Related]
12. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma]. Schneider M, Band P, Amiel JL, Schwarzenberg L, Cattan A, Schlumberger JR, Mathé G. Sem Hop; 1966 Nov 26; 42(49):2952-4. PubMed ID: 4292621 [No Abstract] [Full Text] [Related]
13. Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Carbone PP, Spurr C, Schneiderman M, Scotto J, Holland JF, Shnider B. Cancer Res; 1968 May 26; 28(5):811-22. PubMed ID: 4870882 [No Abstract] [Full Text] [Related]
14. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy]. Danieli G. G Clin Med; 1966 Aug 26; 47(8):732-68. PubMed ID: 4865460 [No Abstract] [Full Text] [Related]
15. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]. Marthé G, Misset JL, de Vassal F, Hayat M, Gouveia J, Machover D, Belpomme D, Schwarzenberg L, Ribaud P, Pico JL, Musset M, Jasmin C, de Luca L. Nouv Presse Med; 1978 Feb 18; 7(7):525-8. PubMed ID: 273888 [Abstract] [Full Text] [Related]
16. [The use of vinblastine and vincristine in the combined therapy of tumors]. Cardinali G, Nervi C. Tumori; 1968 Feb 18; 54(5):345-51. PubMed ID: 4884251 [No Abstract] [Full Text] [Related]
17. Management of patients with non-Hodgkin's lymphoma. Carbone PP. Arch Intern Med; 1973 Mar 18; 131(3):455-9. PubMed ID: 4569377 [No Abstract] [Full Text] [Related]
18. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine. Mathé G, Misset JL, De Vassal F, Gouveia J, Hayat M, Machover D, Belpomme D, Pico JL, Schwarzenberg L, Ribaud P, Musset M, Jasmin C, De Luca L. Cancer Treat Rep; 1978 May 18; 62(5):805-9. PubMed ID: 274996 [Abstract] [Full Text] [Related]
19. Vincristine therapy of lymphomas and chronic lymphocytic leukemia. Desal DV, Ezdinli EZ, Stutzman L. Cancer; 1970 Aug 18; 26(2):352-9. PubMed ID: 4916023 [No Abstract] [Full Text] [Related]
20. [Place of Vinca rosea alkaloids (Catharanthus roseus) in the treatment of Hodgkin's disease]. Cardinali G. Haematologica; 1973 Aug 18; 53(1):51-64. PubMed ID: 4198540 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]